Xan Pharma Labs Private Limited
About Xan Pharma Labs Private Limited
Data last updated:
Xan Pharma Labs Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51900TN2012PTC089086. Its GSTIN is 33AAACX1332K1ZK (Tamil Nadu).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Lakshminarayanan Sunetha and Chandrasekharan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 78/16 Soorappa Street Triplicane, Chennai, Tamil Nadu, India – 600005.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.61 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹1,344 (net margin -0.1%) and EBITDA of ₹2,519 (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Xan Pharma Labs Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address78/16 Soorappa Street Triplicane, Chennai, Tamil Nadu, India – 600005
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Xan Pharma Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xan Pharma Labs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Xan Pharma Labs Private Limited, buy the company report.
Financials of Xan Pharma Labs Private Limited
FY 2025 filings availableXan Pharma Labs Private Limited reported revenue of ₹10.61 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,519 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,344 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xan Pharma Labs Private Limited, buy the company report.
Board of directors of Xan Pharma Labs Private Limited
Xan Pharma Labs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshminarayanan Sunetha | Director | 19 Dec 2012 | 13 Years 10 Months | Current |
| Chandrasekharan | Director | 19 Dec 2012 | 13 Years 10 Months | Current |
Auditor
Xan Pharma Labs Private Limited is audited by M SUKUMAR AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M SUKUMAR AND ASSOCIATES | FY 2017 | 014039S |
Shareholding
The shareholding of Xan Pharma Labs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Xan Pharma Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xan Pharma Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xan Pharma Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xan Pharma Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACX1332K1ZK | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xan Pharma Labs Private Limited, buy the company report.
Recent activity
Xan Pharma Labs Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Balasubramaniam Jayakumar ceased to be Director on 15 Feb 2017.
Frequently asked questions
Xan Pharma Labs is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 December 2012 (14+ years old) and is registered under CIN U51900TN2012PTC089086.
Xan Pharma Labs has 2 current directors:
- Lakshminarayanan Sunetha - Director
- Chandrasekharan - Director
The latest financial statements of Xan Pharma Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Xan Pharma Labs is 33AAACX1332K1ZK, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Xan Pharma Labs is U51900TN2012PTC089086. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xan Pharma Labs was incorporated on 19 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.
Balasubramaniam Jayakumar ceased to be Director on 15 Feb 2017. Somu Baskaran ceased to be Director on 15 Feb 2017. Venkatraman Balaji ceased to be Director on 01 Apr 2014. Xan Pharma Labs has 5 board changes on record in total.
The registered office of Xan Pharma Labs is at 7816 Soorappa Street Triplicane, Chennai, Tamil Nadu, India – 600005.
Xan Pharma Labs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Xan Pharma Labs is compliant as of 06 July 2026. The company is actively filing with the Registrar of Companies.